[Study on the effect of diallyl sulfide on peripheral nerve injury in n-hexane intoxicated rats]

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Jan 20;38(1):1-6. doi: 10.3760/cma.j.issn.1001-9391.2020.01.001.
[Article in Chinese]

Abstract

Objective: To investigate the antagonistic effect of diallyl sulfide (DAS) against peripheral nerve injury induced by n-hexane in rats. Methods: A total of 68 adult male Wistar rats were selected, among which 50 were randomly selected and divided into blank control group, DAS control group (100 mg/kg·bw) , n-hexane model group, low-dose DAS intervention group (50 mg/kg·bw) , and high-dose DAS intervention group (100 mg/kg·bw) . A rat model of peripheral nerve injury was established by n-hexane exposure, and the rats were treated with DAS at different doses. The changes in pyrrole adducts and behavior were observed, a metabolic analysis was performed for serum pyrrole adducts, and the intervention effect was evaluated. The remaining 18 rats were randomly assigned to the n-hexane model group, the low-dose DAS intervention group, and the high-dose DAS intervention group, with 6 rats in each group, as satellite groups used for the toxicokinetic analysis of serum pyrrole adducts. Results: Compared with the blank control group, the n-hexane model group and low-and high-dose DAS intervention groups had a significant reduction in body weight since week 2 (P<0.01) . Compared with the n-hexane model group at the end of the experiment at week 7, the high-dose DAS intervention group had a significantly higher body weight (P<0.05) , while there was no significant difference in body weight between the n-hexane model group and the low-dose DAS intervention group (P>0.05) . The n-hexane model group developed gait abnormality at week 2 of poisoning, while the low-and high-dose DAS intervention groups developed gait abnormality at weeks 3 and 5 of poisoning, respectively. At the end of the experiment, the n-hexane model group and the low-and high-dose DAS intervention groups had a significantly higher gait score than the blank control group (P<0.01) . At the end of the experiment, the n-hexane model group and the low-dose DAS intervention group had significantly shorter latency in rotarod test than the blank control group (P<0.01) , while there was no significant difference in latency between the DAS control group and the high-dose DAS intervention group (P>0.05) . Compared with the n-hexane model group, the low-and high-dose DAS intervention groups had a significant increase in latency in rotarod test (P<0.01) . Compared with blank control group, the n-hexane model group and the low-dose DAS intervention group had a significant increase in mean nerve conduction velocity (P<0.01) , while there was no significant difference between the blank control group and the DAS control group or high-dose DAS intervention group (P>0.05) , and compared with the n-hexane model group, the low-and high-dose DAS intervention groups had a significant increase in nerve conduction velocity (P<0.01) . Compared with the blank control group at the end of the experiment at week 7, the n-hexane model group and the low-and high-dose DAS intervention groups had significant increases in the concentration of pyrrole adducts in serum, urine, and hair (P<0.01) , while there was no significant difference between the blank control group and the DAS control group (P>0.05) , and the high-dose DAS intervention group had a significantly lower concentration of pyrrole adducts in serum, urine, and hair than the low-dose DAS intervention group (P<0.05) . Serum pyrrole adducts reached the peak level at 9-12 hours and then started to decrease. Compared with the n-hexane model group, the high-and low-dose DAS intervention groups had a significantly shorter half-life period of serum pyrrole adducts (P<0.01) . Compared with the n-hexane model group, the high-and low-dose DAS intervention groups had a significant reduction in the area under the curve of serum pyrrole adducts (P<0.05) . Conclusion: DAS can antagonize peripheral nerve injury induced by n-hexane.

目的: 探讨二烯丙基一硫(DAS)对正己烷中毒大鼠周围神经损伤的干预效果。 方法: 成年雄性Wistar大鼠68只,随机选取50只分为5组:空白对照组、DAS对照组(100 mg/kg·bw)、正己烷模型组、DAS低剂量干预组(50 mg/kg·bw)、DAS高剂量干预组(100 mg/kg·bw)。正己烷染毒建立大鼠周围神经损伤模型,使用不同剂量的DAS进行干预,监测大鼠的行为学改变及吡咯加合物变化,并进行血清吡咯加合物的代谢分析,评价干预效果。另选18只大鼠随机分配到正己烷模型组、DAS低剂量干预组、DAS高剂量干预组中,每组各6只,作为卫星组,于第4周进行血清吡咯加合物的代谢动力学研究。 结果: 从第2周开始,与空白对照组比较,正己烷模型组、DAS低剂量干预组、DAS高剂量干预组大鼠体重均降低,差异均有统计学意义(P<0.01)。在第7周实验终点,与正己烷模型组比较,DAS高剂量干预组体重增加(P<0.05),DAS低剂量干预组体重差异无统计学意义(P>0.05)。正己烷模型组、DAS低剂量干预组、DAS高剂量干预组大鼠依次在染毒第2、3、5周开始出现步态异常。在实验终点,与空白对照组比较,正己烷模型组、DAS低剂量干预组、DAS高剂量干预组大鼠步态评分均增高(P<0.01),正己烷模型组、DAS低剂量干预组大鼠转棒潜伏期均缩短(P<0.01)。与DAS对照组比较,DAS高剂量干预组大鼠转棒潜伏期差异无统计学意义(P>0.05)。与正己烷模型组比较,DAS低剂量和DAS高剂量组大鼠转棒潜伏期均增加,差异均有统计学意义(P<0.01)。与空白对照组比较,正己烷模型组、DAS低剂量干预组大鼠的平均神经传导速度均提高,差异均有统计学意义(P<0.01)。与空白对照组比较,DAS对照组和DAS高剂量干预组神经传导速度差异均无统计学意义(P>0.05)。与正己烷模型组比较,DAS低剂量和高剂量干预组大鼠神经传导速度均提高,差异均有统计学意义(P<0.01)。在第7周实验终点,与空白对照组比较,正己烷模型组、DAS低剂量干预组、DAS高剂量干预组大鼠血清、尿、毛发吡咯加合物浓度均升高(P<0.01),DAS对照组大鼠血清、尿、毛发吡咯加合物浓度差异均无统计学意义(P>0.05)。在第7周实验终点,与DAS低剂量干预组比较,DAS高剂量干预组大鼠血清、尿、毛发吡咯加合物浓度均降低,差异均有统计学意义(P<0.05)。大鼠血清吡咯加合物在9~12 h达到峰值,之后开始下降。与正己烷模型组比较,DAS低剂量和高剂量干预组大鼠血清吡咯加合物的半衰期变短、曲线下面积减少,差异均有统计学意义(P<0.05)。 结论: DAS可能拮抗正己烷引起的大鼠周围神经病变。.

Keywords: Diallyl sulfide; N-hexane; Nerve injury; Peripheral nerves; Poisoning; Pyrrole adducts; Rats.

MeSH terms

  • Allyl Compounds / pharmacology*
  • Animals
  • Hexanes / toxicity*
  • Male
  • Peripheral Nerve Injuries / chemically induced
  • Peripheral Nerve Injuries / drug therapy*
  • Rats
  • Rats, Wistar
  • Sulfides / pharmacology*

Substances

  • Allyl Compounds
  • Hexanes
  • Sulfides
  • n-hexane
  • allyl sulfide